What formal requirement must be included in the CDTM agreement?

The formal requirement that must be included in a Collaborative Drug Therapy Management (CDTM) agreement is decision criteria and plans for therapeutic decisions. This is vital because a CDTM agreement outlines the responsibilities of pharmacists and the referring physician in managing a patient’s medication therapy. By including detailed decision criteria, the agreement establishes a clear framework that guides pharmacists in making therapeutic decisions, allowing for evidence-based practices that ensure patient safety and optimal therapeutic outcomes. This framework is essential for ensuring that both the physician and pharmacist have a shared understanding of the parameters for treatment, which contributes to more effective management of patient care.

Patient demographics alone do not provide the necessary clinical guidelines required for collaborative management, while costs of medication, although important in practice, do not directly influence the therapeutic decision-making process outlined in the agreement. Similarly, while follow-up procedures are important in the context of patient care, they are ancillary to the core therapeutic decision-making aspect that the agreement must emphasize. Hence, the inclusion of decision criteria and plans for therapeutic decisions is crucial in solidifying the collaborative relationship and ensuring effective patient management.